Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.79 CAD | -1.25% | -1.25% | -4.82% |
Business Summary
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Cannabis
100.0
%
| 28 | 99.9 % | 52 | 100.0 % | +83.52% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 28 | 99.9 % | 52 | 100.0 % | +83.52% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Zohar Krivorot
CEO | Chief Executive Officer | 48 | 18-12-30 |
Nicholas Sosiak
DFI | Director of Finance/CFO | - | 19-03-31 |
Avi Krivorot
CTO | Chief Tech/Sci/R&D Officer | - | 21-03-31 |
Anthony Manouk
CMP | Compliance Officer | - | 18-10-31 |
France Landry
HRO | Human Resources Officer | - | 19-03-31 |
Scott Carroll
SAM | Sales & Marketing | - | 22-02-28 |
Brian Sherman
LAW | General Counsel | - | 21-09-30 |
Noemi Follain
AUD | Comptroller/Controller/Auditor | - | 19-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jacob M. Kay
BRD | Director/Board Member | 83 | 19-05-24 |
Donald Olds
BRD | Director/Board Member | 64 | 20-11-09 |
Zohar Krivorot
CEO | Chief Executive Officer | 48 | 18-12-30 |
Derek Stern
BRD | Director/Board Member | 57 | 18-12-30 |
Mary Durocher
BRD | Director/Board Member | - | 20-05-24 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 90,018,952 | 45,531,555 ( 50.58 %) | 0 | 50.58 % |
Company contact information
Cannara Biotech, Inc.
333 Décarie Boulevard Suite 200
H4N 3M9, Montréal
+514-543-4200
http://www.cannara.caSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-4.82% | 52.67M | |
-.--% | 339M | |
+26.34% | 277M | |
+12.37% | 253M | |
+43.02% | 194M | |
+146.60% | 144M | |
+34.76% | 132M | |
-43.53% | 123M | |
-28.57% | 121M | |
-7.69% | 93.71M |
- Stock Market
- Equities
- LOVE Stock
- Company Cannara Biotech Inc.